Future studies should focus on whether leptin alone or the adiponectin/leptin ratio is diagnostic or useful for treatment or survival indications for pancreatic adenocarcinoma patients, and especially ones who also have the co-morbid condition of obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.